NEW YORK, April 11, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"), of the important May 26, 2026 lead...
Hence then, the article about ibrx investors have opportunity to lead immunitybio inc securities fraud lawsuit first filed by the rosen law firm was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm )
Also on site :
- GTA 6 dev Rockstar have seemingly been hacked again, but they don't seem all that worried
- We Love Taking Our Babies to the Playground. Only One of Them Is Welcome.
- 'Came here in good faith but ... ': JD Vance on why Iran peace talks failed